Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
Abdo A. Elfiky
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
In-silicoapproaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel
Manoj Kumar Gupta et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Dexamethasone in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta 1 heterodimer
Sundy N. Y. Yang et al.
ANTIVIRAL RESEARCH (2020)
Structure analysis of the receptor binding of 2019-nCoV
Yun Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
Carlos Chaccour et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More
Abinit Saha et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
Abinit Saha et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak
Chiranjib Chakraborty et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2
Sairaj Satarker et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Hongzhou Lu
BIOSCIENCE TRENDS (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples
Yongjian Wu et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
Ashleigh Shannon et al.
ANTIVIRAL RESEARCH (2020)
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
Craig R. Rayner et al.
ANTIVIRAL RESEARCH (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
Derek K. Chu et al.
LANCET (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Masaki Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
COVID-19 Vaccine: A comprehensive status report
Simran Preet Kaur et al.
VIRUS RESEARCH (2020)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Jonathan A. C. Sterne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19
Amir Hossein Mansourabadi et al.
LIFE SCIENCES (2020)
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients
Reed B. Hogan et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2020)
Genomic characterization of a novel SARS-CoV-2
Rozhgar A. Khailany et al.
GENE REPORTS (2020)
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Bo Ram Beck et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C
Lai Wei et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology
Satoru Eguchi et al.
HYPERTENSION (2018)
The mechanism of resistance to favipiravir in influenza
Daniel H. Goldhill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases
Md Abdul Alim Al-Bari
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
Bioinformatics and functional analyses of coronavirus nonstructural proteins involved in the formation of replicative organelles
Benjamin W. Neuman
ANTIVIRAL RESEARCH (2016)
A review of treatment modalities for Middle East Respiratory Syndrome
Yin Mo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
SARS-CoV ORF1b-encoded nonstructural proteins 12-16: Replicative enzymes as antiviral targets
Lorenzo Subissi et al.
ANTIVIRAL RESEARCH (2014)
Arbidol as a broad-spectrum antiviral: An update
Julie Blaising et al.
ANTIVIRAL RESEARCH (2014)
Clinical experience of IL-6 blockade in rheumatic diseases-Implications on IL-6 biology and disease pathogenesis
Ruth Davies et al.
SEMINARS IN IMMUNOLOGY (2014)
Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease
Kiira Ratia et al.
PLOS PATHOGENS (2014)
Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
M. Y. F. Tay et al.
ANTIVIRAL RESEARCH (2013)
Characterization of a Critical Interaction between the Coronavirus Nucleocapsid Protein and Nonstructural Protein 3 of the Viral Replicase-Transcriptase Complex
Kelley R. Hurst et al.
JOURNAL OF VIROLOGY (2013)
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
Cem Gabay et al.
LANCET (2013)
Severe Acute Respiratory Syndrome Coronavirus Nonstructural Proteins 3, 4, and 6 Induce Double-Membrane Vesicles
Megan M. Angelini et al.
MBIO (2013)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
Monitoring of S Protein Maturation in the Endoplasmic Reticulum by Calnexin Is Important for the Infectivity of Severe Acute Respiratory Syndrome Coronavirus
Masaya Fukushi et al.
JOURNAL OF VIROLOGY (2012)
RNA 3′-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex
Mickael Bouvet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Coronavirus nsp6 proteins generate autophagosomes from the endoplasmic reticulum via an omegasome intermediate
Eleanor M. Cottam et al.
AUTOPHAGY (2011)
Biochemical and Structural Insights into the Mechanisms of SARS Coronavirus RNA Ribose 2′-O-Methylation by nsp16/nsp10 Protein Complex
Yu Chen et al.
PLOS PATHOGENS (2011)
An Interaction between the Nucleocapsid Protein and a Component of the Replicase-Transcriptase Complex Is Crucial for the Infectivity of Coronavirus Genomic RNA
Kelley R. Hurst et al.
JOURNAL OF VIROLOGY (2010)
In Vitro Reconstitution of SARS-Coronavirus mRNA Cap Methylation
Mickael Bouvet et al.
PLOS PATHOGENS (2010)
Severe Acute Respiratory Syndrome Coronavirus nsp9 Dimerization Is Essential for Efficient Viral Growth
Zachary J. Miknis et al.
JOURNAL OF VIROLOGY (2009)
Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase
Yu Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)
Scott D. Seiwert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
History of Immunoglobulin Replacement
Martha M. Eibl
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells
Krishna Narayananj et al.
JOURNAL OF VIROLOGY (2008)
Role of the coronavirus E viroporin protein transmembrane domain in virus assembly
Ye Ye et al.
JOURNAL OF VIROLOGY (2007)
A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus
Isabelle Imbert et al.
EMBO JOURNAL (2006)
Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation
Wataru Kamitani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron ciyomicroscopy
Benjamin W. Neuman et al.
JOURNAL OF VIROLOGY (2006)
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Hossein A. Ghofrani et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Mechanisms of action of ribavirin against distinct viruses
JD Graci et al.
REVIEWS IN MEDICAL VIROLOGY (2006)
Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer
YJ Zhai et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1-phosphate dephosphorylation by a conserved domain of nsP3
KS Saikatendu et al.
STRUCTURE (2005)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Design of wide-spectrum inhibitors targeting coronavirus main proteases
HT Yang et al.
PLOS BIOLOGY (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
CK Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
The nsp9 replicase protein of SARS-coronavirus, structure and functional insights
G Sutton et al.
STRUCTURE (2004)
Major genetic marker of nidoviruses encodes a replicative endoribonuclease
KA Ivanov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity
BH Harcourt et al.
JOURNAL OF VIROLOGY (2004)
Human coronavirus 229E nonstructural protein 13:: Characterization of duplex-unwinding, nucleoside triphosphatase, and RNA 5′-triphosphatase activities
KA Ivanov et al.
JOURNAL OF VIROLOGY (2004)
The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor
K Bhardwaj et al.
JOURNAL OF VIROLOGY (2004)
Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein
QL Huang et al.
BIOCHEMISTRY (2004)
Mechanisms and enzymes involved in SARS coronavirus genome expression
V Thiel et al.
JOURNAL OF GENERAL VIROLOGY (2003)
RNA virus error catastrophe: Direct molecular test by using ribavirin
S Crotty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Intracellular functions of N-linked glycans
A Helenius et al.
SCIENCE (2001)
Virus-encoded proteinases and proteolytic processing in the Nidovirales
J Ziebuhr et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Share Paper
